> Skip repeated content

New medication guidelines for rheumatic disease patients having joint replacement

Science Daily—June 17, 2017

An expert panel of rheumatologists and orthopedic surgeons have developed guidelines to reduce risk of infection for rheumatic patients after a hip or knee replacement, according to Science Daily.

HSS rheumatologist Susan M. Goodman, MD was a co-principal investigator. "Patients with rheumatic diseases who have joint replacement surgery are at increased risk for joint infection, a potentially devastating complication," she said.

Dr. Goodman added, "as infection risk is linked to the use of anti-rheumatic medication, our goal was to develop recommendations on when to stop medication prior to joint replacement and the optimal time for patients to restart treatment after surgery."

The American College of Rheumatology (ACR) and the American Association of Hip and Knee Surgeons sponsored the project. The guidelines were published in Arthritis Care & Research.

One of the main recommendations was "biologic medications should be withheld as close to one dosing cycle as scheduling permits prior to elective hip or knee replacement and restarted after evidence of wound healing, typically 14 days, for all patients with rheumatic diseases."

Read the full article at sciencedaily.com


Need Help Finding a Physician?

Call us toll-free at:

Media Contacts


Social Media Contacts